Table 2.
Anti-complement capacity of chondroitin sulfates (CSs) from three sources and the depolymerized derivatives.
| Sample | Line Equation | IC50 (mg) |
|---|---|---|
| LMWCS-B-A | y = 0.0967x + 0.7583 R = 0.989 | 5.59 |
| LMWCS-P-A | y = 0.11x + 1.8179 R = 0.989 | 7.32 |
| LMWCS-S-A | y = 0.0703x + 1.2167 R = 0.9599 | 4.76 |
| LMWCS-B-E | y = 0.0703x + 0.8147 R = 0.980 | 4.33 |
| LMWCS-P-E | y = 0.064x + 1.8861 R = 0.992 | 5.09 |
| LMWCS-S-E | y = 0.0589x + 1.2021 R = 0.977 | 4.15 |
| LMWCS-B-M | y = 0.1016x − 1.3729 R = 0.984 | 3.71 |
| LMWCS-P-M | y = 0.0613x + 1.5563 R = 0.994 | 4.62 |
| LMWCS-S-M | y = 0.0815x + 1.1212 R = 0.991 | 5.20 |
| LMWCS-B-O | y = 0.0891x + 0.3776 R = 0.994 | 4.83 |
| LMWCS-P-O | y = 0.0573x + 1.425 R = 0.975 | 4.29 |
| LMWCS-S-O | y = 0.0565x + 0.5873 R = 0.988 | 3.41 |
| CS-B | y = 0.1029x + 1.0596 R = 0.993 | 6.20 |
| CS-P | y = 0.1499x + 1.5709 R = 0.988 | 9.07 |
| CS-S | y = 0.0902x − 0.0251 R = 0.987 | 4.48 |